Literature DB >> 2876205

High cyclosporin levels after bone marrow transplantation associated with hypertriglyceridaemia.

J Nemunaitis, H J Deeg, G C Yee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2876205     DOI： 10.1016/s0140-6736(86)90254-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Cyclosporin A pharmacokinetics in a patient with psoriasis and obesity, presenting with high levels of low-density [correction for destiny] lipoprotein.

Authors:  Tomoki Okuda; Tsunao Oh-i
Journal:  Eur J Clin Pharmacol       Date:  2002-07       Impact factor: 2.953

Review 2.  Optimisation of immunosuppressive therapy using pharmacokinetic principles.

Authors:  J Grevel
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

Review 3.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

4.  Cyclosporine transfer from low- and high-density lipoproteins is partially influenced by lipid transfer protein I triglyceride transfer activity.

Authors:  K M Wasan; R Subramanian; J W Chou; M Ramaswamy; P H Pritchard
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

Review 5.  Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.

Authors:  T Oura; A B Cosimi; T Kawai
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

6.  Effects of hyperlipidemia on the pharmacokinetics of nifedipine in the rat.

Authors:  L A Eliot; R T Foster; F Jamali
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

Review 7.  Distribution of cyclosporin in organ transplant recipients.

Authors:  Fatemeh Akhlaghi; Andrew K Trull
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Monitoring of the free concentration of cyclosporine in plasma in man.

Authors:  A Lindholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

9.  Cyclosporine binds to the neutral lipid and potentially other binding sites of lipid transfer protein I.

Authors:  Mona Kwong; Kishor M Wasan
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

Review 10.  Adverse reactions and interactions of cyclosporin.

Authors:  J P Scott; T W Higenbottam
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.